Silybin inhibits NLRP3 inflammasome assembly through the NAD+/SIRT2 pathway in mice with nonalcoholic fatty liver disease
Published 2018 View Full Article
- Home
- Publications
- Publication Search
- Publication Details
Title
Silybin inhibits NLRP3 inflammasome assembly through the NAD+/SIRT2 pathway in mice with nonalcoholic fatty liver disease
Authors
Keywords
-
Journal
FASEB JOURNAL
Volume 32, Issue 2, Pages 757-767
Publisher
FASEB
Online
2017-10-03
DOI
10.1096/fj.201700602r
References
Ask authors/readers for more resources
Related references
Note: Only part of the references are listed.- Increased risk of mortality by fibrosis stage in nonalcoholic fatty liver disease: Systematic review and meta-analysis
- (2017) Parambir S. Dulai et al. HEPATOLOGY
- Hepatic NAD+deficiency as a therapeutic target for non-alcoholic fatty liver disease in ageing
- (2016) Can-Can Zhou et al. BRITISH JOURNAL OF PHARMACOLOGY
- Curcumin inhibits lipolysis via suppression of ER stress in adipose tissue and prevents hepatic insulin resistance
- (2016) Lulu Wang et al. JOURNAL OF LIPID RESEARCH
- Structural insights into HDAC6 tubulin deacetylation and its selective inhibition
- (2016) Yasuyuki Miyake et al. Nature Chemical Biology
- Role of NLRP3 Inflammasome in the Progression of NAFLD to NASH
- (2016) Xingyong Wan et al. Canadian Journal of Gastroenterology and Hepatology
- A pharmacological inhibitor of NLRP3 inflammasome prevents non-alcoholic fatty liver disease in a mouse model induced by high fat diet
- (2016) Gabsik Yang et al. Scientific Reports
- Hesperidin and Silibinin Ameliorate Aluminum-Induced Neurotoxicity: Modulation of Antioxidants and Inflammatory Cytokines Level in Mice Hippocampus
- (2015) Ashok Jangra et al. BIOLOGICAL TRACE ELEMENT RESEARCH
- Exploring NAD+ metabolism in host–pathogen interactions
- (2015) Inês Mesquita et al. CELLULAR AND MOLECULAR LIFE SCIENCES
- Tubulin acetylation: responsible enzymes, biological functions and human diseases
- (2015) Lin Li et al. CELLULAR AND MOLECULAR LIFE SCIENCES
- SIRT2 regulates microtubule stabilization in diabetic cardiomyopathy
- (2015) Qiong Yuan et al. EUROPEAN JOURNAL OF PHARMACOLOGY
- Regulation of inflammasome activation
- (2015) Si Ming Man et al. IMMUNOLOGICAL REVIEWS
- Initiation and perpetuation of NLRP3 inflammasome activation and assembly
- (2015) Eric I. Elliott et al. IMMUNOLOGICAL REVIEWS
- Mitochondria: diversity in the regulation of the NLRP3 inflammasome
- (2015) Prajwal Gurung et al. TRENDS IN MOLECULAR MEDICINE
- The effects of different doses of silibinin in combination with methotrexate on testicular tissue of mice
- (2014) Hayder Gaeed Oufi et al. EUROPEAN JOURNAL OF PHARMACOLOGY
- Structural mechanisms of inflammasome assembly
- (2014) Alvin Lu et al. FEBS Journal
- Silybin exerts antioxidant effects and induces mitochondrial biogenesis in liver of rat with secondary biliary cirrhosis
- (2014) Gaetano Serviddio et al. FREE RADICAL BIOLOGY AND MEDICINE
- NLRP3 inflammasome activation is required for fibrosis development in NAFLD
- (2014) Alexander Wree et al. JOURNAL OF MOLECULAR MEDICINE-JMM
- Mitochondrial form and function
- (2014) Jonathan R. Friedman et al. NATURE
- Thioredoxin-interacting protein is required for endothelial NLRP3 inflammasome activation and cell death in a rat model of high-fat diet
- (2013) Islam N. Mohamed et al. DIABETOLOGIA
- The NLRP3 Inflammasome as a Novel Player of the Intercellular Crosstalk in Metabolic Disorders
- (2013) Elisa Benetti et al. MEDIATORS OF INFLAMMATION
- Microtubule-driven spatial arrangement of mitochondria promotes activation of the NLRP3 inflammasome
- (2013) Takuma Misawa et al. NATURE IMMUNOLOGY
- Rebuilding the balance of STAT1 and STAT3 signalings by fusaruside, a cerebroside compound, for the treatment of T-cell-mediated fulminant hepatitis in mice
- (2012) Xing-Xin Wu et al. BIOCHEMICAL PHARMACOLOGY
- Elovl6 promotes nonalcoholic steatohepatitis
- (2012) Takashi Matsuzaka et al. HEPATOLOGY
- Inflammasomes in liver diseases
- (2012) Gyongyi Szabo et al. JOURNAL OF HEPATOLOGY
- Inflammasomes in health and disease
- (2012) Till Strowig et al. NATURE
- Fatty acid and endotoxin activate inflammasomes in mouse hepatocytes that release danger signals to stimulate immune cells
- (2011) Timea Csak et al. HEPATOLOGY
- Nonalcoholic Fatty Liver Disease: Pathology and Pathogenesis
- (2010) Dina G. Tiniakos et al. Annual Review of Pathology-Mechanisms of Disease
- The Inflammasomes
- (2010) Kate Schroder et al. CELL
- Evolution of inflammation in nonalcoholic fatty liver disease: The multiple parallel hits hypothesis
- (2010) Herbert Tilg et al. HEPATOLOGY
- Poly(ADP-ribose) polymerase-1 (PARP-1) and its therapeutic implications
- (2010) Rupinder K. Sodhi et al. VASCULAR PHARMACOLOGY
- Silymarin Ascending Multiple Oral Dosing Phase I Study in Noncirrhotic Patients With Chronic Hepatitis C
- (2009) Roy L. Hawke et al. JOURNAL OF CLINICAL PHARMACOLOGY
- Mitofusin 2 Builds a Bridge between ER and Mitochondria
- (2008) Carsten Merkwirth et al. CELL
- Mitofusin 2 tethers endoplasmic reticulum to mitochondria
- (2008) Olga Martins de Brito et al. NATURE
Find Funding. Review Successful Grants.
Explore over 25,000 new funding opportunities and over 6,000,000 successful grants.
ExploreAdd your recorded webinar
Do you already have a recorded webinar? Grow your audience and get more views by easily listing your recording on Peeref.
Upload Now